Universal Ready-to-Use Immunotherapeutic Approach for the Treatment of Cancer: Expanded and Activated Polyclonal γδ Memory T Cells

In the last years, important progresses have been registered in the treatment of patients suffering from oncological/haematological malignancies, but more still needs to be done to reduce toxicity and side effects, improve outcome and offer new strategies for relapsed or refractory disease. A remark...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Immunol
Main Authors: Polito, Vinicia A., Cristantielli, Rosaria, Weber, Gerrit, Del Bufalo, Francesca, Belardinilli, Tamascia, Arnone, Claudia M., Petretto, Andrea, Antonucci, Laura, Giorda, Ezio, Tumino, Nicola, Pitisci, Angela, De Angelis, Biagio, Quintarelli, Concetta, Locatelli, Franco, Caruana, Ignazio
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2019
Assuntos:
Immunology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6883509/
https://ncbi.nlm.nih.gov/pubmed/31824502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.02717
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares